Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial

被引：3
|
作者：
O'Meara, Eileen [1 ]
Prescott, Margaret F. [2 ]
Rouleau, Jean L. [1 ]
Chiang, Lu-May [2 ]
Solomon, Scott D. [3 ]
Swedberg, Karl [4 ]
Packer, Milton [5 ]
McMurray, John J. V. [6 ]
Zile, Michael R. [7 ]
机构：
[1] Montreal Heart Inst, Montreal, PQ, Canada
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Baylor Univ, Med Ctr, Dallas, TX USA
[6] Univ Glasgow, Glasgow, Lanark, Scotland
[7] Med Univ South Carolina, Charleston, SC USA
来源：
JOURNAL OF CARDIAC FAILURE | 2016年 / 22卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2016.06.094
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
077
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [31] Levels of sST2 and NT-proBNP biomarkers in patients with acute coronary syndrome and subclinical hypothyroidism
    Kuz, N. B.
    Solomenchuk, T. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2024, 26 (03) : 178 - 183
  • [32] Persistently elevated levels of sST2 after acute coronary syndrome are associated with recurrent cardiac events
    van den Berg, Victor. J.
    Vroegindewey, Maxime M.
    Umans, Victor A.
    van der Harst, Pim
    Asselbergs, Folkert W.
    Akkerhuis, K. Martijn
    Kardys, Isabella
    Boersma, Eric
    BIOMARKERS, 2022, 27 (03) : 264 - 269
  • [33] Comments on association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease
    Mansori, Kamyar
    Ayubi, Erfan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 : 32 - 32
  • [34] Relationship between soluble protein ST2 (sST2) levels and microvascular complications in a cohort of patients with type 1 diabetes
    Forga, Luis
    Lopez-Andres, Natalia
    Tamayo, Ibai
    Fernandez-Celis, Amaya
    Garcia-Mouriz, Marta
    Jose Goni, Maria
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2022, 69 (05): : 322 - 330
  • [35] Sacubitril/valsartan: from the PARADIGM-HF trial results to heart failure patients in internal medicine. A narrative review
    Verdiani, Valerio
    ITALIAN JOURNAL OF MEDICINE, 2021, 15 (01) : 17 - 26
  • [36] Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
    Mapelli, Massimo
    Mattavelli, Irene
    Salvioni, Elisabetta
    Bonomi, Alice
    Capra, Nicolo
    Palermo, Pietro
    Banfi, Cristina
    Paolillo, Stefania
    Biondi, Maria Luisa
    Agostoni, Piergiuseppe
    DRUGS IN R&D, 2023, 23 (04) : 397 - 402
  • [37] Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
    Massimo Mapelli
    Irene Mattavelli
    Elisabetta Salvioni
    Alice Bonomi
    Nicolò Capra
    Pietro Palermo
    Cristina Banfi
    Stefania Paolillo
    Maria Luisa Biondi
    Piergiuseppe Agostoni
    Drugs in R&D, 2023, 23 : 397 - 402
  • [38] Preoperative sST2 levels relate to myocardial remodeling and cardiac function improvement after cardiac valve surgery
    Zhu, Yan
    Pei, Lipeng
    Li, Ning
    Zhu, Yan
    ESC HEART FAILURE, 2024, 11 (01): : 91 - 98
  • [39] Serum sST2 and Gal-3 Levels in Patients on Veno-Arterial Extracorporeal Life Support
    Kassier, Adnan
    Kort, Eric J.
    Shrestha, Nabin Manandhar
    Acharya, Deepak
    Lee, Sangjin
    Dickinson, Michael
    Jovinge, Stefan
    Loyaga-Rendon, Renzo
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S22 - S22
  • [40] sST2 levels and 3D speckle tracking as predictors of CAD severity in chronic coronary syndrome
    Amr Setouhi
    K. Maghraby
    Nasser Taha
    M. Abdelsayed
    Mohammed H. Hassan
    Hossam Eldin M. Mahmoud
    The Egyptian Heart Journal, 76 (1)
12345